脊柱用生物製剤の世界市場:同種移植片、幹細胞、BMP、DBM、合成移植骨...市場調査レポートについてご紹介

【英文タイトル】Global Spine Biologics Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Spine biologics: An overview
• Clinical need for biologics in spine surgeries
• Funding in spine biologics
• Spine biologic products under clinical trials

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Market segmentation by product
• Allograft
• Stem cells
• BMP
• DBM
• Synthetic bone grafts

PART 08: Global spine biologics market by allograft
• Market size and forecast

PART 09: Global spine biologics market by stem cells
• Market overview
• Market size and forecast

PART 10: Global spine biologics market by BMP
• Market overview

PART 11: Global spine biologics market by DBM
• Market overview
• Market size and forecast

PART 12: Global spine biologics market by synthetic bone grafts
• Market overview

PART 13: Geographical segmentation
• Spine biologics market in Americas
• Spine biologics market in EMEA
• Spine biologics market in APAC

PART 14: Key leading countries
• US
• Japan
• Germany

PART 15: Market drivers
• Increased incidence of spinal disorders
• Growing popularity of MI spinal and robot-assisted surgeries
• Rise in strategic partnerships for marketing
• Increase in older population

PART 16: Impact of drivers

PART 17: Market challenges
• Complications associated with spine implants in surgeries
• Stringent regulatory and reimbursement policies
• High cost of spinal fusion surgery
• Intense competition
• Poor performance of bone graft substitute

PART 18: Impact of drivers and challenges

PART 19: Market trends
• Advances in technology
• Rise in popularity of physician-owned ASCs
• Emerging MI sacroiliac joint fusion technique
• Product development in collaboration with research institutes
• Increase in M&A

PART 20: Vendor landscape
• Competitive scenario
• Market share analysis
• Medtronic
• Johnson & Johnson
• Stryker
• NuVasive
• Zimmer Biomet
• SeaSpine
• Other prominent vendors

PART 21: Appendix
• List of abbreviations

PART 22: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Spine fusion techniques
Exhibit 03: Funding for development of spine biologics
Exhibit 04: List of spine biologic products under clinical trials
Exhibit 05: Spine market model 2015
Exhibit 06: Global spine biologics market 2015-2020 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Segmentation of global spine biologics market by product type
Exhibit 09: Global spine biologics market segmentation by product type 2015
Exhibit 10: Global spine biologics market by allografts 2015-2020 ($ millions)
Exhibit 11: Global spine biologics market by stem cells 2015-2020 ($ millions)
Exhibit 12: Global spine biologics market by BMP 2015-2020 ($ millions)
Exhibit 13: Global spine biologics market by DBM 2015-2020 ($ millions)
Exhibit 14: Global spine biologics market by synthetic bone grafts 2015-2020 ($ millions)
Exhibit 15: Segmentation of global spine biologics market by product type 2015-2020 ($ millions)
Exhibit 16: Segmentation of global spine biologics market by product type 2015-2020 (%)
Exhibit 17: Global spine biologics market by geography 2015
Exhibit 18: Global spine biologics market by geography 2020
Exhibit 19: Spine biologics market in Americas 2015-2020 ($ billions)
Exhibit 20: Spine biologics market in EMEA 2015-2020 ($ millions)
Exhibit 21: Spine biologics market in APAC 2015-2020 ($ millions)
Exhibit 22: Global spine biologics market by geography 2015-2020 ($ millions)
Exhibit 23: Global spine biologics market by geography 2015-2020
Exhibit 24: Population aged 60 years and above: World, developed, and developing regions 1950-2050 (millions)
Exhibit 25: Impact of drivers
Exhibit 26: Comparison of the cost of spine surgeries 2015
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Ranking of top six vendors 2015
Exhibit 29: Market share of vendors 2015
Exhibit 30: Collaboration between vendors and universities or organizations
Exhibit 31: Medtronic: Product portfolio
Exhibit 32: Medtronic: Restorative Therapies group by revenue 2013-2015 ($ billions)
Exhibit 33: Medtronic: Key takeaways
Exhibit 34: Johnson & Johnson: Product portfolio
Exhibit 35: Johnson & Johnson: Key takeaways
Exhibit 36: Stryker: Product portfolio
Exhibit 37: Stryker: Orthopedics segment by revenue 2013-2015 ($ billions)
Exhibit 38: Stryker: Key takeaways
Exhibit 39: NuVasive: Product portfolio
Exhibit 40: NuVasive: Biologics segment by revenue 2013-2015 ($ millions)
Exhibit 41: NuVasive: Key takeaways
Exhibit 42: Zimmer Biomet: Product portfolio
Exhibit 43: Zimmer Biomet: Key takeaways
Exhibit 44: SeaSpine: Product portfolio
Exhibit 45: SeaSpine: Orthopedics segment by revenue 2013-2015 ($ millions)
Exhibit 46: SeaSpine: Key takeaways
Exhibit 47: Other prominent vendors


【レポート販売概要】

■ タイトル:脊柱用生物製剤の世界市場:同種移植片、幹細胞、BMP、DBM、合成移植骨
■ 英文:Global Spine Biologics Market 2016-2020
■ 発行日:2016年6月8日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9386
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。